Bharat Biotech manufactured Covaxin most probable to be globally authorised by August-end, according to the latest reports by CNN News 18. The vaccine is seeking to get World Health Organisation (WHO)’s approval for emergency use on global terms.
As per News18, WHO officials and Health Minister Mansukh Mandaviya will meet today to negotiate on WHO’s approval for Covaxin. The government has reportedly followed due diligence for the authorization, appealed during the first week of July.
On July 28, the Minister of State for Health Bharati Pravin Pawar told Rajya Sabha that all the required documents for Emergency Use Listing (EUL) have been duly submitted by Bharat Biotech to WHO.
Earlier today, the Drugs Controller General of India (DCGI) had passed a trial of a mix of Covishield and Covaxin, conducted in Christian Medical College, Vellore.
The approval comes after 11 days once the Subject Expert Committee (SEC) of the CDSCO (Central Drugs Standard Control Organisation) suggested the grant for the mix-and-match test and trial.
A thorough study conducted by ICMR with 98 people, 18 of whom incidentally received the Covishield vaccine earlier as the first dose and Covaxin as the second dose in Uttar Pradesh showcased that this combination of vaccines has proved to be more propitious with improved immunogenicity of both the vaccines.
This study also featured immunisation that was secure wherein the adverse effects were discovered to be similar to the same dose regimen.
